Appointment of Alex Hughes as CFO | 01-Mar-2023 | 07:01 | RNS |
BiVictriX reports positive BVX001 preclinical data | 31-Jan-2023 | 07:08 | RNS |
Holding(s) in Company | 24-Jan-2023 | 16:21 | RNS |
Holding(s) in Company | 19-Jan-2023 | 11:00 | RNS |
Holding(s) in Company | 19-Jan-2023 | 07:00 | RNS |
Holding(s) in Company | 16-Jan-2023 | 16:32 | RNS |
BiVictriX: Board Change | 06-Jan-2023 | 07:00 | RNS |
BiVictriX identifies lead for BVX001 programme | 07-Dec-2022 | 07:00 | RNS |
Holding(s) in Company | 28-Sep-2022 | 10:40 | RNS |
Holding(s) in Company | 27-Sep-2022 | 07:00 | RNS |
Director Dealing | 15-Sep-2022 | 15:36 | RNS |
Director Dealing | 13-Sep-2022 | 07:00 | RNS |
BiVictriX Interim Results | 12-Sep-2022 | 07:00 | RNS |
Pipeline update | 11-Jul-2022 | 07:00 | RNS |
Holding(s) in Company | 05-Jul-2022 | 09:16 | RNS |
Currency | UK Pounds |
Share Price | 14.50p |
Change Today | -1.50p |
% Change | -9.38 % |
52 Week High | 25.50 |
52 Week Low | 14.25 |
Volume | 26,772 |
Shares Issued | 66.12m |
Market Cap | £9.59m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:35 | 417 @ 14.50p |
16:35 | 417 @ 14.50p |
11:12 | 18,855 @ 14.25p |
10:25 | 7,500 @ 15.00p |
You are here: research